
Nanomedicine in the Treatment and Management of Alzheimer's Disease
- English
- ePUB (mobile friendly)
- Available on iOS & Android
Nanomedicine in the Treatment and Management of Alzheimer's Disease
About this book
This book aims to discuss the various drug delivery approaches of neuroprotective medicines via nanoparticles, such as enzymes, monoclonal antibodies, neurotrophic factors, pharmaceutical drugs, and nucleic acid-based medication, to manage Alzheimer's disease.
Nanomedicine in the Treatment and Management of Alzheimer's Disease investigates drug administration approaches, either separately or in combination, to improve neuroprotection in Alzheimer's disease. The book examines various novel therapeutic applications of nanomaterials in drug delivery for the central nervous system in Alzheimer's disease treatment. The book explores the role of nanoparticles in crossing the bloodābrain barrier and blood-CSF barrier in the treatment and management of Alzheimer's disease. The authors also explain the nanoparticle-based delivery of therapeutic molecules including phytochemicals, peptides, siRNA, enzymes, and monoclonal antibodies in the treatment of Alzheimer's disease. Finally, the book also discusses the various challenges and future perspectives of nanomedicine in the management of Alzheimer's disease.
The book will help in bridging the gap of knowledge in neurosciences, neurotherapeutics, nanotechnology, and nanomedicine domains. The book chapter may be useful to educators, researchers, legislators, and medical professionals including pharmacologists, biochemists, corporate pharma R&D researchers, neurologists, and scientists involved in neurodegenerative diseases and nanomedicine.
Frequently asked questions
- Essential is ideal for learners and professionals who enjoy exploring a wide range of subjects. Access the Essential Library with 800,000+ trusted titles and best-sellers across business, personal growth, and the humanities. Includes unlimited reading time and Standard Read Aloud voice.
- Complete: Perfect for advanced learners and researchers needing full, unrestricted access. Unlock 1.4M+ books across hundreds of subjects, including academic and specialized titles. The Complete Plan also includes advanced features like Premium Read Aloud and Research Assistant.
Please note we cannot support devices running on iOS 13 and Android 7 or earlier. Learn more about using the app.
Information
Table of contents
- Cover Page
- Half-Title Page
- Title Page
- Copyright Page
- Dedication Page
- Contents
- About the Editors
- List of Contributors
- Acknowledgment
- Preface
- Chapter 1 Overview of Neuropathology of Alzheimerās Disease
- Chapter 2 Current Therapeutic Targets and Approaches in the Treatment of Alzheimerās Disease
- Chapter 3 Pharmacological Approaches to Alleviate Neuroinflammation in Alzheimerās Disease
- Chapter 4 Nanotechnological Advances in the Delivery of CNS Therapeutics
- Chapter 5 Nanomedicine: A Promising Way to Manage Alzheimerās Disease
- Chapter 6 Gold Nanoparticles-Based Drug Delivery for Treatment and Management of Alzheimerās Disease
- Chapter 7 Lipid-Based Nanocarrier in the Management of Alzheimerās Disease
- Chapter 8 Chitosan-Based Nanoparticles in the Treatment of Alzheimerās Disease
- Chapter 9 Polymeric Nanoparticles-Based Therapeutic Strategies for Alzheimerās Disease
- Chapter 10 Carbon Dots: Blood-Brain Barrier Penetrating Drug Nanocarrier in the Treatment of Alzheimerās Disease
- Chapter 11 Nanoparticles-Based Immunotherapeutic Strategies for the Treatment of Alzheimerās Disease
- Chapter 12 Nanoparticles-Based siRNA Delivery in the Treatment and Management of Alzheimerās Disease
- Chapter 13 Engineering Nanoparticles in Drug Delivery for Alzheimerās Disease Treatment
- Chapter 14 Recent Progress of Nanomedicine in the Treatment of Alzheimerās Disease
- Chapter 15 Challenges and Opportunities of Nanomedicines in Clinical Translation
- Index